2020
DOI: 10.26434/chemrxiv.12400604.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Structural Analysis of COVID-19 Main Protease and its Interaction with the Inhibitor N3

Abstract: <i>Here, we analyze the structural features of a ligand binding domain (LBD) in COVID-19 main protease (MP) followed by the interactions between the inhibitor N3 and MP-LBD residues through the molecular dynamics simulations. The time based changes in physical parameters that includes root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of gyration (RG), dihedral distributions, residue velocity, radial distribution function (RDF) and H-bonding signify the degrees of folding stat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…PDB . The structural analysis as well as viral protein-drug interaction can be studied by the methods of computation as explained in the recent literatures (Lamichhane and Ghimire, 2020;Wu, et al, 2020;Muralidharan, et al, 2020;Al-Khafaji , et al, 2020;Mirza, et al, 2020). According to Lamichhane and Ghimire (2020), the structural analysis of nCoV main protease (MP) liganded with inhibitor N3 has been performed in terms of the physical parameters such as root mean square deviation, root mean square fluctuation, radius of gyration, residue velocity, dihedral angle distributions, radial distribution function (RDF) and H-bonding, and the interactions between MP residues in the ligand binding domain (LBD) and inhibitor N3 have been studied in terms of electrostatic and van der Waals energies by means of MD simulations.…”
Section: Tribhuvan University Journal Covid-19 Special Issue Vol 34 Sep 2020mentioning
confidence: 99%
See 3 more Smart Citations
“…PDB . The structural analysis as well as viral protein-drug interaction can be studied by the methods of computation as explained in the recent literatures (Lamichhane and Ghimire, 2020;Wu, et al, 2020;Muralidharan, et al, 2020;Al-Khafaji , et al, 2020;Mirza, et al, 2020). According to Lamichhane and Ghimire (2020), the structural analysis of nCoV main protease (MP) liganded with inhibitor N3 has been performed in terms of the physical parameters such as root mean square deviation, root mean square fluctuation, radius of gyration, residue velocity, dihedral angle distributions, radial distribution function (RDF) and H-bonding, and the interactions between MP residues in the ligand binding domain (LBD) and inhibitor N3 have been studied in terms of electrostatic and van der Waals energies by means of MD simulations.…”
Section: Tribhuvan University Journal Covid-19 Special Issue Vol 34 Sep 2020mentioning
confidence: 99%
“…To the time of writing this report (23 rd June, 2020), no actual drugs or vaccines has been prescribed so far by WHO for COVID-19 treatment. Several drugs or inhibitors of SARS-CoV-2 such as inhibitor N3 Lamichhane and Ghimire, 2020) remdecivir (Wang, et al, 2020) favipiravir (Cai, et al, 2020), arbidol (Dong, et al, 2020) and dexomethasone (Heidi Ledford, Nature News 2020)are still under preclinical or clinical practices. It is necessary to test the efficacy and safety of the drugs or vaccines before prescribing them for the general public to investigate the medicine which actually works against COVID-19.…”
Section: Possible Drugs Under Studymentioning
confidence: 99%
See 2 more Smart Citations